127 related articles for article (PubMed ID: 20634064)
1. Anti-T. cruzi activities and QSAR studies of 3-arylquinoxaline-2-carbonitrile di-N-oxides.
Vicente E; Duchowicz PR; Benítez D; Castro EA; Cerecetto H; González M; Monge A
Bioorg Med Chem Lett; 2010 Aug; 20(16):4831-5. PubMed ID: 20634064
[TBL] [Abstract][Full Text] [Related]
2. Exploring 3-arylquinoxaline-2-carbonitrile 1,4-di-N-oxides activities against neglected diseases with QSAR.
Vicente E; Duchowicz PR; Ortiz Edel V; Monge A; Castro EA
Chem Biol Drug Des; 2010 Jul; 76(1):59-69. PubMed ID: 20492446
[TBL] [Abstract][Full Text] [Related]
3. QSAR analysis for quinoxaline-2-carboxylate 1,4-di-N-oxides as anti-mycobacterial agents.
Vicente E; Duchowicz PR; Castro EA; Monge A
J Mol Graph Model; 2009 Aug; 28(1):28-36. PubMed ID: 19394254
[TBL] [Abstract][Full Text] [Related]
4. Mode of action of nifurtimox and N-oxide-containing heterocycles against Trypanosoma cruzi: is oxidative stress involved?
Boiani M; Piacenza L; Hernández P; Boiani L; Cerecetto H; González M; Denicola A
Biochem Pharmacol; 2010 Jun; 79(12):1736-45. PubMed ID: 20178775
[TBL] [Abstract][Full Text] [Related]
5. Improving anti-trypanosomal activity of 3-aminoquinoxaline-2-carbonitrile N1,N4-dioxide derivatives by complexation with vanadium.
Urquiola C; Vieites M; Aguirre G; Marín A; Solano B; Arrambide G; Noblía P; Lavaggi ML; Torre MH; González M; Monge A; Gambino D; Cerecetto H
Bioorg Med Chem; 2006 Aug; 14(16):5503-9. PubMed ID: 16709457
[TBL] [Abstract][Full Text] [Related]
6. New potent 5-substituted benzofuroxans as inhibitors of Trypanosoma cruzi growth: quantitative structure-activity relationship studies.
Aguirre G; Boiani L; Boiani M; Cerecetto H; Di Maio R; González M; Porcal W; Denicola A; Piro OE; Castellano EE; Sant'Anna CM; Barreiro EJ
Bioorg Med Chem; 2005 Dec; 13(23):6336-46. PubMed ID: 16202608
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationship of new growth inhibitors of Trypanosoma cruzi.
Cinque GM; Szajnman SH; Zhong L; Docampo R; Schvartzapel AJ; Rodriguez JB; Gros EG
J Med Chem; 1998 Apr; 41(9):1540-54. PubMed ID: 9554887
[TBL] [Abstract][Full Text] [Related]
8. Benzo[1,2-c]1,2,5-oxadiazole N-oxide derivatives as potential antitrypanosomal drugs. Part 3: Substituents-clustering methodology in the search for new active compounds.
Aguirre G; Boiani L; Cerecetto H; Di Maio R; González M; Porcal W; Denicola A; Möller M; Thomson L; Tórtora V
Bioorg Med Chem; 2005 Dec; 13(23):6324-35. PubMed ID: 16115774
[TBL] [Abstract][Full Text] [Related]
9. Imidazolidines as new anti-Trypanosoma cruzi agents: biological evaluation and structure-activity relationships.
Caterina MC; Perillo IA; Boiani L; Pezaroglo H; Cerecetto H; González M; Salerno A
Bioorg Med Chem; 2008 Mar; 16(5):2226-34. PubMed ID: 18083035
[TBL] [Abstract][Full Text] [Related]
10. Trypanocidal properties, structure-activity relationship and computational studies of quinoxaline 1,4-di-N-oxide derivatives.
Estevez Y; Quiliano M; Burguete A; Cabanillas B; Zimic M; Málaga E; Verástegui M; Pérez-Silanes S; Aldana I; Monge A; Castillo D; Deharo E
Exp Parasitol; 2011 Apr; 127(4):745-51. PubMed ID: 21272583
[TBL] [Abstract][Full Text] [Related]
11. New potent imidazoisoquinolinone derivatives as anti-Trypanosoma cruzi agents: biological evaluation and structure-activity relationships.
Bollini M; Casal JJ; Alvarez DE; Boiani L; González M; Cerecetto H; Bruno AM
Bioorg Med Chem; 2009 Feb; 17(4):1437-44. PubMed ID: 19168363
[TBL] [Abstract][Full Text] [Related]
12. 5-Nitro-2-furyl derivative actives against Trypanosoma cruzi: preliminary in vivo studies.
Cabrera E; Murguiondo MG; Arias MG; Arredondo C; Pintos C; Aguirre G; Fernández M; Basmadjián Y; Rosa R; Pacheco JP; Raymondo S; Di Maio R; González M; Cerecetto H
Eur J Med Chem; 2009 Oct; 44(10):3909-14. PubMed ID: 19446929
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of quinoxaline di-N-oxide derivatives with in vitro trypanocidal activity.
Pérez-Silanes S; Torres E; Arbillaga L; Varela J; Cerecetto H; González M; Azqueta A; Moreno-Viguri E
Bioorg Med Chem Lett; 2016 Feb; 26(3):903-906. PubMed ID: 26750255
[TBL] [Abstract][Full Text] [Related]
14. Novel quinoxaline 1,4-di-N-oxide derivatives as new potential antichagasic agents.
Torres E; Moreno-Viguri E; Galiano S; Devarapally G; Crawford PW; Azqueta A; Arbillaga L; Varela J; Birriel E; Di Maio R; Cerecetto H; González M; Aldana I; Monge A; Pérez-Silanes S
Eur J Med Chem; 2013 Aug; 66():324-34. PubMed ID: 23811257
[TBL] [Abstract][Full Text] [Related]
15. Computational discovery of novel trypanosomicidal drug-like chemicals by using bond-based non-stochastic and stochastic quadratic maps and linear discriminant analysis.
Castillo-Garit JA; Vega MC; Rolon M; Marrero-Ponce Y; Kouznetsov VV; Torres DF; Gómez-Barrio A; Bello AA; Montero A; Torrens F; Pérez-Giménez F
Eur J Pharm Sci; 2010 Jan; 39(1-3):30-6. PubMed ID: 19854271
[TBL] [Abstract][Full Text] [Related]
16. Naphthoquinoidal [1,2,3]-triazole, a new structural moiety active against Trypanosoma cruzi.
da Silva EN; Menna-Barreto RF; Pinto Mdo C; Silva RS; Teixeira DV; de Souza MC; De Simone CA; De Castro SL; Ferreira VF; Pinto AV
Eur J Med Chem; 2008 Aug; 43(8):1774-80. PubMed ID: 18045742
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, trypanocidal activity and docking studies of novel quinoxaline-N-acylhydrazones, designed as cruzain inhibitors candidates.
Romeiro NC; Aguirre G; Hernández P; González M; Cerecetto H; Aldana I; Pérez-Silanes S; Monge A; Barreiro EJ; Lima LM
Bioorg Med Chem; 2009 Jan; 17(2):641-52. PubMed ID: 19110434
[TBL] [Abstract][Full Text] [Related]
18. Trypanocidal activity of 4 isopropyl salicylaldehyde and 4-isopropyl salicylic acid on Trypanosoma cruzi.
Nogueda-Torres B; Rodríguez-Paez L; Ramírez IB; Ramírez CW
Rev Latinoam Microbiol; 2001; 43(1):1-6. PubMed ID: 17061565
[TBL] [Abstract][Full Text] [Related]
19. Pyrimido[1,2-a]quinoxaline 6-oxide and phenazine 5,10-dioxide derivatives and related compounds as growth inhibitors of Trypanosoma cruzi.
Lavaggi ML; Aguirre G; Boiani L; Orelli L; García B; Cerecetto H; González M
Eur J Med Chem; 2008 Aug; 43(8):1737-41. PubMed ID: 18068272
[TBL] [Abstract][Full Text] [Related]
20. Quinoxaline N,N'-dioxide derivatives and related compounds as growth inhibitors of Trypanosoma cruzi. Structure-activity relationships.
Aguirre G; Cerecetto H; Di Maio R; González M; Alfaro ME; Jaso A; Zarranz B; Ortega MA; Aldana I; Monge-Vega A
Bioorg Med Chem Lett; 2004 Jul; 14(14):3835-9. PubMed ID: 15203172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
